You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

CLINICAL TRIALS PROFILE FOR LIPOFEN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LIPOFEN

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01752842 ↗	Lipid Biomarkers for Diabetic Heart Disease	Completed	Leducq Foundation	N/A	2013-03-01	This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗	Lipid Biomarkers for Diabetic Heart Disease	Completed	National Heart, Lung, and Blood Institute (NHLBI)	N/A	2013-03-01	This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗	Lipid Biomarkers for Diabetic Heart Disease	Completed	National Institutes of Health (NIH)	N/A	2013-03-01	This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗	Lipid Biomarkers for Diabetic Heart Disease	Completed	Washington University School of Medicine	N/A	2013-03-01	This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT02158273 ↗	Medication Development in Alcoholism: Investigating PPAR Agonists	Completed	National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Phase 2	2014-05-01	The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
NCT02158273 ↗	Medication Development in Alcoholism: Investigating PPAR Agonists	Completed	The Scripps Research Institute	Phase 2	2014-05-01	The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LIPOFEN

Condition Name

Chart
Table

Condition Name for LIPOFEN
Intervention	Trials
Diabetes Complications	1
Type II Diabetes Mellitus	1
Alcoholism	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LIPOFEN
Intervention	Trials
Diabetes Mellitus	1
Diabetes Complications	1
Alcoholism	1
Heart Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LIPOFEN

Trials by Country

Map
Table

Trials by Country for LIPOFEN
Location	Trials
United States	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for LIPOFEN
Location	Trials
California	1
Missouri	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LIPOFEN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LIPOFEN
Clinical Trial Phase	Trials
Phase 2	1
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LIPOFEN
Clinical Trial Phase	Trials
Completed	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LIPOFEN

Sponsor Name

Chart
Table

Sponsor Name for LIPOFEN
Sponsor	Trials
Leducq Foundation	1
National Heart, Lung, and Blood Institute (NHLBI)	1
National Institutes of Health (NIH)	1
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LIPOFEN
Sponsor	Trials
Other	3
NIH	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.